Nasdaq · Common stock
Outlook Therapeutics (OTLK)
$0.5133 −$0.01 (−1.16%)
- Day’s range
- $0.4872–$0.5292
- Volume
- 2.5M
OTLK price history
OTLK closed at $0.5133 on Oct. 26, 2026. Over the past year, its daily close ranged from $0.1981 on March 24, 2026 to $2.47 on Dec. 16, 2025.
Data table: OTLK daily closes, the past year
| Date | Close |
|---|---|
| Oct. 26, 2026 | $0.5133 |
| Oct. 23, 2026 | $0.5193 |
| Oct. 22, 2026 | $0.5635 |
| Oct. 21, 2026 | $0.5613 |
| Oct. 20, 2026 | $0.5200 |
| Oct. 19, 2026 | $0.4930 |
| Oct. 16, 2026 | $0.4882 |
| Oct. 15, 2026 | $0.5000 |
| Oct. 14, 2026 | $0.4702 |
| Oct. 13, 2026 | $0.5638 |
| Oct. 12, 2026 | $0.5851 |
| Oct. 9, 2026 | $0.5989 |
| Oct. 8, 2026 | $0.5640 |
| Oct. 7, 2026 | $0.5900 |
| Oct. 6, 2026 | $0.5720 |
| Oct. 5, 2026 | $0.5955 |
| Oct. 2, 2026 | $0.5930 |
| Oct. 1, 2026 | $0.5750 |
| Sept. 30, 2026 | $0.5735 |
| Sept. 29, 2026 | $0.6257 |
| Sept. 28, 2026 | $0.6211 |
| Sept. 25, 2026 | $0.6395 |
| Sept. 24, 2026 | $0.6558 |
| Sept. 23, 2026 | $0.6617 |
| Sept. 22, 2026 | $0.6962 |
| Sept. 21, 2026 | $0.6863 |
| Sept. 18, 2026 | $0.6526 |
| Sept. 17, 2026 | $0.6810 |
| Sept. 16, 2026 | $0.6769 |
| Sept. 15, 2026 | $0.6730 |
| Sept. 14, 2026 | $0.6379 |
| Sept. 11, 2026 | $0.6600 |
| Sept. 10, 2026 | $0.6612 |
| Sept. 9, 2026 | $0.6439 |
| Sept. 8, 2026 | $0.6405 |
| Sept. 4, 2026 | $0.6665 |
| Sept. 3, 2026 | $0.6490 |
| Sept. 2, 2026 | $0.6263 |
| Sept. 1, 2026 | $0.6231 |
| Aug. 31, 2026 | $0.6334 |
| Aug. 28, 2026 | $0.6449 |
| Aug. 27, 2026 | $0.6411 |
| Aug. 26, 2026 | $0.6233 |
| Aug. 25, 2026 | $0.6400 |
| Aug. 24, 2026 | $0.6090 |
| Aug. 21, 2026 | $0.6472 |
| Aug. 20, 2026 | $0.6763 |
| Aug. 19, 2026 | $0.6901 |
| Aug. 18, 2026 | $0.7000 |
| Aug. 17, 2026 | $0.6722 |
| Aug. 14, 2026 | $0.7564 |
| Aug. 13, 2026 | $0.8888 |
| Aug. 12, 2026 | $1.10 |
| Aug. 11, 2026 | $1.13 |
| Aug. 10, 2026 | $1.15 |
| Aug. 7, 2026 | $1.02 |
| Aug. 6, 2026 | $0.9725 |
| Aug. 5, 2026 | $1.03 |
| Aug. 4, 2026 | $0.9602 |
| Aug. 3, 2026 | $0.9130 |
| July 31, 2026 | $0.9766 |
| July 30, 2026 | $1.04 |
| July 29, 2026 | $1.00 |
| July 28, 2026 | $0.9040 |
| July 27, 2026 | $1.07 |
| July 24, 2026 | $1.41 |
| July 23, 2026 | $1.32 |
| July 22, 2026 | $1.34 |
| July 21, 2026 | $1.42 |
| July 20, 2026 | $1.38 |
| July 17, 2026 | $1.39 |
| July 16, 2026 | $1.46 |
| July 15, 2026 | $1.56 |
| July 14, 2026 | $1.73 |
| July 13, 2026 | $1.55 |
| July 10, 2026 | $1.57 |
| July 9, 2026 | $1.68 |
| July 8, 2026 | $1.69 |
| July 7, 2026 | $1.46 |
| July 6, 2026 | $1.42 |
| July 2, 2026 | $1.45 |
| July 1, 2026 | $1.47 |
| June 30, 2026 | $1.59 |
| June 29, 2026 | $1.69 |
| June 26, 2026 | $1.71 |
| June 25, 2026 | $1.61 |
| June 24, 2026 | $1.68 |
| June 23, 2026 | $1.70 |
| June 22, 2026 | $1.83 |
| June 18, 2026 | $1.58 |
| June 17, 2026 | $1.65 |
| June 16, 2026 | $1.57 |
| June 15, 2026 | $1.16 |
| June 12, 2026 | $1.22 |
| June 11, 2026 | $1.10 |
| June 10, 2026 | $0.8900 |
| June 9, 2026 | $0.7047 |
| June 8, 2026 | $0.7220 |
| June 5, 2026 | $0.7767 |
| June 4, 2026 | $0.7948 |
| June 3, 2026 | $0.8098 |
| June 2, 2026 | $0.8136 |
| June 1, 2026 | $0.8430 |
| May 29, 2026 | $0.7300 |
| May 28, 2026 | $0.7400 |
| May 27, 2026 | $0.5855 |
| May 26, 2026 | $0.4002 |
| May 22, 2026 | $0.3099 |
| May 21, 2026 | $0.3330 |
| May 20, 2026 | $0.2730 |
| May 19, 2026 | $0.2284 |
| May 18, 2026 | $0.2292 |
| May 15, 2026 | $0.2281 |
| May 14, 2026 | $0.2332 |
| May 13, 2026 | $0.2300 |
| May 12, 2026 | $0.2425 |
| May 11, 2026 | $0.2477 |
| May 8, 2026 | $0.2213 |
| May 7, 2026 | $0.2157 |
| May 6, 2026 | $0.2318 |
| May 5, 2026 | $0.2417 |
| May 4, 2026 | $0.2625 |
| May 1, 2026 | $0.2622 |
| April 30, 2026 | $0.2500 |
| April 29, 2026 | $0.2564 |
| April 28, 2026 | $0.2621 |
| April 27, 2026 | $0.2850 |
| April 24, 2026 | $0.3151 |
| April 23, 2026 | $0.2869 |
| April 22, 2026 | $0.2902 |
| April 21, 2026 | $0.3194 |
| April 20, 2026 | $0.3700 |
| April 17, 2026 | $0.3092 |
| April 16, 2026 | $0.2704 |
| April 15, 2026 | $0.2730 |
| April 14, 2026 | $0.2530 |
| April 13, 2026 | $0.2544 |
| April 10, 2026 | $0.2490 |
| April 9, 2026 | $0.2222 |
| April 8, 2026 | $0.2501 |
| April 7, 2026 | $0.2130 |
| April 6, 2026 | $0.2006 |
| April 2, 2026 | $0.2190 |
| April 1, 2026 | $0.2100 |
| March 31, 2026 | $0.2058 |
| March 30, 2026 | $0.2010 |
| March 27, 2026 | $0.2081 |
| March 26, 2026 | $0.2100 |
| March 25, 2026 | $0.2080 |
| March 24, 2026 | $0.1981 |
| March 23, 2026 | $0.3198 |
| March 20, 2026 | $0.3511 |
| March 19, 2026 | $0.3362 |
| March 18, 2026 | $0.3500 |
| March 17, 2026 | $0.3957 |
| March 16, 2026 | $0.3519 |
| March 13, 2026 | $0.3940 |
| March 12, 2026 | $0.4210 |
| March 11, 2026 | $0.4341 |
| March 10, 2026 | $0.4450 |
| March 9, 2026 | $0.4476 |
| March 6, 2026 | $0.4140 |
| March 5, 2026 | $0.4318 |
| March 4, 2026 | $0.4385 |
| March 3, 2026 | $0.4216 |
| March 2, 2026 | $0.4220 |
| Feb. 27, 2026 | $0.4207 |
| Feb. 26, 2026 | $0.4333 |
| Feb. 25, 2026 | $0.4397 |
| Feb. 24, 2026 | $0.4110 |
| Feb. 23, 2026 | $0.4000 |
| Feb. 20, 2026 | $0.4131 |
| Feb. 19, 2026 | $0.4346 |
| Feb. 18, 2026 | $0.4096 |
| Feb. 17, 2026 | $0.4223 |
| Feb. 13, 2026 | $0.4900 |
| Feb. 12, 2026 | $0.4410 |
| Feb. 11, 2026 | $0.4694 |
| Feb. 10, 2026 | $0.4209 |
| Feb. 9, 2026 | $0.4046 |
| Feb. 6, 2026 | $0.4294 |
| Feb. 5, 2026 | $0.3900 |
| Feb. 4, 2026 | $0.4000 |
| Feb. 3, 2026 | $0.4300 |
| Feb. 2, 2026 | $0.4400 |
| Jan. 30, 2026 | $0.4397 |
| Jan. 29, 2026 | $0.4599 |
| Jan. 28, 2026 | $0.4488 |
| Jan. 27, 2026 | $0.4972 |
| Jan. 26, 2026 | $0.5078 |
| Jan. 23, 2026 | $0.5030 |
| Jan. 22, 2026 | $0.5100 |
| Jan. 21, 2026 | $0.5060 |
| Jan. 20, 2026 | $0.5200 |
| Jan. 16, 2026 | $0.5462 |
| Jan. 15, 2026 | $0.5222 |
| Jan. 14, 2026 | $0.5400 |
| Jan. 13, 2026 | $0.5614 |
| Jan. 12, 2026 | $0.5742 |
| Jan. 9, 2026 | $0.5900 |
| Jan. 8, 2026 | $0.6043 |
| Jan. 7, 2026 | $0.5900 |
| Jan. 6, 2026 | $0.5295 |
| Jan. 5, 2026 | $0.5426 |
| Jan. 2, 2026 | $0.6600 |
| Dec. 31, 2025 | $1.58 |
| Dec. 30, 2025 | $1.87 |
| Dec. 29, 2025 | $1.98 |
| Dec. 26, 2025 | $1.82 |
| Dec. 24, 2025 | $1.83 |
| Dec. 23, 2025 | $1.86 |
| Dec. 22, 2025 | $1.84 |
| Dec. 19, 2025 | $2.01 |
| Dec. 18, 2025 | $2.07 |
| Dec. 17, 2025 | $2.27 |
| Dec. 16, 2025 | $2.47 |
| Dec. 15, 2025 | $2.17 |
| Dec. 12, 2025 | $1.98 |
| Dec. 11, 2025 | $2.00 |
| Dec. 10, 2025 | $2.09 |
| Dec. 9, 2025 | $2.08 |
| Dec. 8, 2025 | $2.00 |
| Dec. 5, 2025 | $2.05 |
| Dec. 4, 2025 | $2.06 |
| Dec. 3, 2025 | $1.97 |
| Dec. 2, 2025 | $1.83 |
| Dec. 1, 2025 | $1.86 |
| Nov. 28, 2025 | $1.79 |
| Nov. 26, 2025 | $1.68 |
| Nov. 25, 2025 | $1.60 |
| Nov. 24, 2025 | $1.80 |
| Nov. 21, 2025 | $1.88 |
| Nov. 20, 2025 | $1.88 |
| Nov. 19, 2025 | $1.96 |
| Nov. 18, 2025 | $1.91 |
| Nov. 17, 2025 | $1.77 |
| Nov. 14, 2025 | $1.57 |
| Nov. 13, 2025 | $1.47 |
| Nov. 12, 2025 | $1.28 |
| Nov. 11, 2025 | $1.24 |
| Nov. 10, 2025 | $1.26 |
| Nov. 7, 2025 | $1.19 |
| Nov. 6, 2025 | $1.18 |
| Nov. 5, 2025 | $1.25 |
| Nov. 4, 2025 | $1.21 |
| Nov. 3, 2025 | $1.30 |
| Oct. 31, 2025 | $1.26 |
| Oct. 30, 2025 | $1.24 |
| Oct. 29, 2025 | $1.28 |
| Oct. 28, 2025 | $1.33 |
| Oct. 27, 2025 | $1.34 |
Key figures
- 52-week range
- $0.1981–$2.47Low March 24, 2026; high Dec. 16, 2025
- Average daily volume
- 10.8MPast 3 months
- Market value
- $125.0M
- Dividend yield
- —
- From 52-week high
- −79.22%
Price change
- 1 month
- −19.73%
- 3 months
- −63.47%
- Year to date
- −67.51%
- 1 year
- −63.07%
$1,000 a year ago
$1,000 put into OTLK at the close on Oct. 24, 2025 would be worth $369.
Price only, dividends not included.
What Wall Street says about OTLK
In the past 90 days, Wall Street firms published 2 rating or price-target actions on OTLK: 1 reiterated rating and 1 raised price target.
| Action | Rating | |||
|---|---|---|---|---|
| Ascendiant Capital | Raises target | Buy | $10 to $10.50 | |
| BTIG | Reiterates | Buy | $4 |
Ratings and price targets are the firms’ own opinions, reported as published.
Not investment advice.
About Outlook Therapeutics, Inc. Common Stock
Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. The Company have received marketing authorization for an ophthalmic formulation of ONS-5010/LYTENAVA (bevacizumab-gamma) for use in treating wet age-related macular degeneration, or wet AMD, in the European Union, and United Kingdom. The product pipeline includes ONS-5010/LYTENAVA, which is in total eight NORSES; ONS-5010 Clinical Progress, Unmet Patient Needs, New Ophthalmic Anti-VEGF, and Potential First Line Therapy.
- Headquarters
- Iselin, N.J.
- Employees
- 17
- Listed
- May 13, 2016
- Sector
- Health care
- Industry
- Biological products, (no diagnostic substances)
In WallStreetDigest editions
No WallStreetDigest article about OTLK is on the site yet.